JP2006519807A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2006519807A5 JP2006519807A5 JP2006504625A JP2006504625A JP2006519807A5 JP 2006519807 A5 JP2006519807 A5 JP 2006519807A5 JP 2006504625 A JP2006504625 A JP 2006504625A JP 2006504625 A JP2006504625 A JP 2006504625A JP 2006519807 A5 JP2006519807 A5 JP 2006519807A5
- Authority
- JP
- Japan
- Prior art keywords
- formula
- compound
- compounds
- group
- phenyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US45362403P | 2003-03-11 | 2003-03-11 | |
| PCT/EP2004/002460 WO2004080464A1 (en) | 2003-03-11 | 2004-03-10 | Use of isoquinoline derivatives for treating cancer and map kinase related diseases |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2006519807A JP2006519807A (ja) | 2006-08-31 |
| JP2006519807A5 true JP2006519807A5 (enExample) | 2007-04-26 |
Family
ID=32990797
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2006504625A Pending JP2006519807A (ja) | 2003-03-11 | 2004-03-10 | 癌およびｍａｐキナーゼ関連疾患の処置のためのイソキノリン誘導体の使用 |
Country Status (22)
| Country | Link |
|---|---|
| EP (1) | EP1603566B1 (enExample) |
| JP (1) | JP2006519807A (enExample) |
| KR (1) | KR20050108383A (enExample) |
| CN (1) | CN1758910A (enExample) |
| AT (1) | ATE421324T1 (enExample) |
| AU (1) | AU2004218914A1 (enExample) |
| BR (1) | BRPI0408257A (enExample) |
| CA (1) | CA2518530A1 (enExample) |
| DE (1) | DE602004019193D1 (enExample) |
| ES (1) | ES2318276T3 (enExample) |
| HR (1) | HRP20050788A2 (enExample) |
| IS (1) | IS8064A (enExample) |
| MA (1) | MA27724A1 (enExample) |
| MX (1) | MXPA05009687A (enExample) |
| NO (1) | NO20054647L (enExample) |
| PL (1) | PL1603566T3 (enExample) |
| PT (1) | PT1603566E (enExample) |
| RU (1) | RU2325159C2 (enExample) |
| TN (1) | TNSN05223A1 (enExample) |
| TW (1) | TW200501955A (enExample) |
| WO (1) | WO2004080464A1 (enExample) |
| ZA (1) | ZA200506571B (enExample) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2526285A1 (en) | 2003-05-15 | 2004-12-23 | Arqule, Inc. | Inhibitors of p38 and methods of using the same |
| PE20050952A1 (es) * | 2003-09-24 | 2005-12-19 | Novartis Ag | Derivados de isoquinolina como inhibidores de b-raf |
| WO2006010082A1 (en) | 2004-07-08 | 2006-01-26 | Arqule, Inc. | 1,4-disubstituted naphtalenes as inhibitors of p38 map kinase |
| CA2584368A1 (en) | 2004-10-19 | 2006-04-27 | Arqule, Inc. | Synthesis of imidazooxazole and imidazothiazole inhibitors of p38 map kinase |
| WO2006089781A1 (en) * | 2005-02-25 | 2006-08-31 | Novartis Ag | Pharmaceutical combination of bcr-abl and raf inhibitors |
| HRP20110839T1 (hr) * | 2005-07-26 | 2011-12-31 | Sanofi | Derivati cikloheksaminizokinolona kao inhibitori rho-kinaze |
| US8318941B2 (en) | 2006-07-06 | 2012-11-27 | Bristol-Myers Squibb Company | Pyridone/hydroxypyridine 11-beta hydroxysteroid dehydrogenase type I inhibitors |
| JP2009077712A (ja) * | 2007-09-11 | 2009-04-16 | F Hoffmann La Roche Ag | Ｂ−Ｒａｆキナーゼ阻害剤に対する感受性についての診断試験 |
| US8758323B2 (en) | 2009-07-30 | 2014-06-24 | Tandem Diabetes Care, Inc. | Infusion pump system with disposable cartridge having pressure venting and pressure feedback |
| EP2545187B1 (en) | 2010-03-09 | 2018-09-05 | Dana-Farber Cancer Institute, Inc. | Methods of diagnosing and treating cancer in patients having or developing resistance to a first cancer therapy |
| CA2816088A1 (en) | 2010-10-28 | 2012-05-03 | Viamet Pharmaceuticals, Inc. | Metalloenzyme inhibitor compounds |
| CN103435430B (zh) * | 2013-08-08 | 2015-02-18 | 四川大学 | 一种还原酰胺类化合物的方法 |
| KR102119943B1 (ko) | 2018-05-23 | 2020-06-05 | 주식회사 포스코 | 시편배치유닛 및 이를 포함하는 도장밀착성 실험장치 |
| US20210275516A1 (en) * | 2018-07-02 | 2021-09-09 | Ecole Polytechnique Federale De Lausanne (Epfl) | Lactate enhancing compounds and uses thereof |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW544448B (en) * | 1997-07-11 | 2003-08-01 | Novartis Ag | Pyridine derivatives |
| ES2342240T3 (es) * | 1998-08-11 | 2010-07-02 | Novartis Ag | Derivados de isoquinolina con actividad que inhibe la angiogenia. |
| AR025752A1 (es) * | 1999-09-28 | 2002-12-11 | Bayer Corp | Piridinas y piridacinas sustituidas con actividad de inhibicion de angiogenesis |
| WO2001058899A1 (en) * | 2000-02-09 | 2001-08-16 | Novartis Ag | Pyridine derivatives inhibiting angiogenesis and/or vegf receptor tyrosine kinase |
| US20030078271A1 (en) * | 2001-01-31 | 2003-04-24 | Blackburn Thomas P. | Use of GAL3 receptor antagonists for the treatment of depression and/or anxiety and compounds useful in such methods |
| ATE497603T1 (de) * | 2001-03-02 | 2011-02-15 | Gpc Biotech Ag | Drei-hybrid-assaysystem |
| CA2471314A1 (en) * | 2001-12-21 | 2003-07-24 | Bayer Pharmaceuticals Corporation | Anti-angiogenesis combination therapies comprising pyridazine or pyridine derivatives |
| US7220775B2 (en) * | 2002-08-07 | 2007-05-22 | H. Lundbeck A/S | Compound useful for the treatment of neuropathic pain |
-
2004
- 2004-03-10 KR KR1020057016936A patent/KR20050108383A/ko not_active Ceased
- 2004-03-10 JP JP2006504625A patent/JP2006519807A/ja active Pending
- 2004-03-10 WO PCT/EP2004/002460 patent/WO2004080464A1/en not_active Ceased
- 2004-03-10 EP EP04718960A patent/EP1603566B1/en not_active Expired - Lifetime
- 2004-03-10 RU RU2005131168/04A patent/RU2325159C2/ru not_active IP Right Cessation
- 2004-03-10 CA CA002518530A patent/CA2518530A1/en not_active Abandoned
- 2004-03-10 BR BRPI0408257-5A patent/BRPI0408257A/pt not_active IP Right Cessation
- 2004-03-10 TW TW093106341A patent/TW200501955A/zh unknown
- 2004-03-10 PT PT04718960T patent/PT1603566E/pt unknown
- 2004-03-10 HR HR20050788A patent/HRP20050788A2/xx not_active Application Discontinuation
- 2004-03-10 CN CNA2004800065706A patent/CN1758910A/zh active Pending
- 2004-03-10 DE DE602004019193T patent/DE602004019193D1/de not_active Expired - Lifetime
- 2004-03-10 MX MXPA05009687A patent/MXPA05009687A/es active IP Right Grant
- 2004-03-10 PL PL04718960T patent/PL1603566T3/pl unknown
- 2004-03-10 AU AU2004218914A patent/AU2004218914A1/en not_active Abandoned
- 2004-03-10 ES ES04718960T patent/ES2318276T3/es not_active Expired - Lifetime
- 2004-03-10 AT AT04718960T patent/ATE421324T1/de active
-
2005
- 2005-08-17 ZA ZA200506571A patent/ZA200506571B/en unknown
- 2005-09-09 TN TNP2005000223A patent/TNSN05223A1/en unknown
- 2005-09-23 MA MA28511A patent/MA27724A1/fr unknown
- 2005-10-10 NO NO20054647A patent/NO20054647L/no not_active Application Discontinuation
- 2005-10-10 IS IS8064A patent/IS8064A/is unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2001252272B2 (en) | Substituted benzoic acid amides and use thereof for the inhibition of angiogenesis | |
| CN112239469A (zh) | 靶向蛋白降解c-Met降解剂及其制备方法与应用 | |
| JP6786086B2 (ja) | １，３，５−トリアジン誘導体及びその使用方法 | |
| JP2006502119A5 (enExample) | ||
| JP2016525075A5 (enExample) | ||
| CA1320204C (en) | Pharmaceutically useful dihydropyridinyldicarboxylate amides and esters | |
| JP2018520109A (ja) | ピリド−アザヘテロサイクリック化合物及びその製造方法と用途 | |
| JP2005516969A (ja) | メタボトロピックグルタミン酸受容体−５のヘテロアリール置換ピロールモジュレーター | |
| MX2009008465A (es) | Nuevas 2-aminooxazolinas como ligandos de taar1. | |
| WO2004002963A1 (ja) | アミド誘導体及び医薬 | |
| JP2006508979A5 (enExample) | ||
| KR20120076350A (ko) | 키나아제 억제제, 이의 전구약물 형태 및 이들의 치료 용도 | |
| JP2010505861A5 (enExample) | ||
| JP2003513066A5 (enExample) | ||
| JP2019533007A5 (enExample) | ||
| JP2023547346A5 (enExample) | ||
| RU2004117595A (ru) | Производные пиридина в качестве лигандов рецептора nmda | |
| JP2005504790A5 (enExample) | ||
| JP2003512471A5 (enExample) | ||
| KR20150079677A (ko) | 디아실글리세롤 아실트랜스퍼라제 억제제로서의 신규 화합물 | |
| KR960007594A (ko) | 2,3- 다리걸친 1,4-디히드로피리딘, 그의 제조 방법 및 그의 약제로서의 용도 | |
| JP2011515441A5 (enExample) | ||
| JPH0316955B2 (enExample) | ||
| JP2007529471A5 (enExample) | ||
| PT1446381E (pt) | Amidas do ácido antranílico e a sua utilização farmacêutica |